Hemptouch is a small family company from Slovenia specialising in topicals, namely natural creams and ointments that are CBD-rich and support skin health. Co-founder Silvija Špehar has a passion for natural skincare and saw the potential of CBD for topical use in synergetic formulas rich in essential oils and organic ingredients. When Hemptouch launched in 2014, Silvija’s formulas soon became popular via word of mouth and today has grown to become one of the most influential European CBD skincare brands. Widely retailed in the UK, Hemptouch offers the guarantee of overseeing the entire production process - from the growing of Cannabis Sativa L. in their own fields to the formulation and manufacturing of their products for topical use. Hemptouch also supplies a medium-strength 15% extract in an olive oil base. If you’re looking for quality CBD products from an ethical, small, European manufacturer, you’ll like Hemptouch.
You’ve most likely heard of CBD. It is becoming an increasingly popular choice for an array of health complaints and conditions. It is one of 104 cannabinoids, which are specific chemical compounds found in the Cannabis sativa plant. Unlike its sister cannabinoid, THC, CBD provides all the benefits of Cannabis without the psychoactive effects. In other words, it won’t make you high. While many full-spectrum CBD oils contain trace amounts of THC, the amount is negligible and has no noticeable effects.
This study combats the notion that CBD causes a THC high by discussing the misinterpretations of prior studies on the subject. In fact, the researchers state that two particular prior studies “have caused much confusion and uncertainty whether oral cannabidiol (CBD) is safe and whether subjects who are treated with CBD run the risk of positive workplace tests [for THC].”
These reports suffered from a number of design flaws, including incomplete baseline quantification of baseline seizure frequency, indeterminate time periods for outcome determination and, in some cases, inadequate (or missing) statistical analysis—in general, a lack of sufficient detail to adequately evaluate and interpret the findings. Limitations aside, several studies did report that administration of adjunctive CBD did not result in meaningful changes in seizure frequency (11–13).
Furthermore, a study published in the Journal of Neuroendocrinology has suggested that the ECS is capable of stimulating specific areas of the body involved in metabolism, such as the skeletal muscles and GI tract. This happens due to the presence of anandamide and 2-AG, which are two naturally-occurring compounds in the body that interact with the CB1 and CB2 receptors.
CBD, a non-psychoactive cannabis compound has helped improve the health of many people. It is known for its capability to treat a wide variety of illnesses. Some of the conditions that can be cured by cannabidiol include anxiety, pain, insomnia and even cancer. Humans and pets stand to benefit a lot from the use of CBD products. You should not be afraid of CBD because it is non-psychoactive. The chances of getting high after using it are nil. Tetrahydrocannabinol also referred to as THC is the substance in cannabis responsible for getting one high.
By commenting on this post I agree to give source information for any health/medical information that is not my personal experience or general knowledge. I understand that personal experience is any symptom, test, treatment, etc. that I or a close family member has undergone himself/herself. I understand that my comment will not be approved unless I provide trustworthy sources for all statements regarding statistics, data, studies, and new advancement in medicine.
In addition to acting on the brain, CBD influences many body processes. That’s due to the endocannabinoid system (ECS), which was discovered in the 1990s, after scientists started investigating why pot produces a high. Although much less well-known than the cardiovascular, reproductive, and respiratory systems, the ECS is critical. “The ECS helps us eat, sleep, relax, forget what we don’t need to remember, and protect our bodies from harm,” Marcu says. There are more ECS receptors in the brain than there are for opioids or serotonin, plus others in the intestines, liver, pancreas, ovaries, bone cells, and elsewhere.

“There's not much more to say than it being perfect at what it is, a high quality lip balm. There is no off taste as I expected, rather it had a mild vanilla earthy taste after being applied. The actual balm is a dark green colour but there is no strange colour on your lips after using it. It doesn't feel greasy at all, it gets quickly absorbed and feels nice and soft after a while. I'd definitely buy some again.”
The increased activity of the pancreas in an attempt to secrete additional insulin can cause inflammation throughout the gland. That chronic inflammation can actually destroy the beta cells which are the sites that secrete insulin. This downward spiral diminishes the body’s ability to make insulin at all – a dangerous path that can lead to diabetes.

When administered alone, CBD is an effective anticonvulsant in maximal electrical shock (MES), magnesium-free, 4-aminopyridine, and audiogenic models (7, 8). Co-administration with AEDs leads to various effects; anticonvulsant effects of CBD are enhanced with phenytoin or phenobarbital but decreased with chlordiazepoxide, clonazepam, trimethadione, and ethosuximide. In a recent study using an acute pilocarpine model, although CBD administration reduced the number of animals displaying seizure activity, CBD did not appear to have any significant effect on the number of seizures per animal (7).
CBD is readily obtainable in most parts of the United States, though its exact legal status is in flux. All 50 states have laws legalizing CBD with varying degrees of restriction, and while the federal government still considers CBD in the same class as marijuana, it doesn’t habitually enforce against it. In December 2015, the FDA eased the regulatory requirements to allow researchers to conduct CBD trials. Currently, many people obtain CBD online without a medical cannabis license. The government’s position on CBD is confusing, and depends in part on whether the CBD comes from hemp or marijuana. The legality of CBD is expected to change, as there is currently bipartisan consensus in Congress to make the hemp crop legal which would, for all intents and purposes, make CBD difficult to prohibit.
Cunha et al. reported a 2-phase pilot study of CBD versus placebo in normal volunteers and patients with refractory secondarily generalized epilepsy (14). In the first phase, 8 normal volunteers received CBD or placebo in a doubled-blind fashion, at a dose of 3 mg/kg for 30 days. The second phase was also double-blinded in 15 patients with epilepsy receiving 200 to 300 mg daily of CBD or placebo for 135 days. Patients continued baseline AED. All subjects tolerated CBD well, with no serious adverse events. Four of the epilepsy patients receiving CBD were “almost free of convulsive crisis” for the duration of the study. Three other patients receiving CBD had a partial reduction in seizures, and 1 subject had no response. Of the 7 patients receiving placebo, seizure frequency was unchanged in 6, and 1 had clear improvement in seizure control.
Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy—especially in children with Dravet syndrome—using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy. This review highlights some of the basic science theory behind the use of CBD, summarizes published data on clinical use of CBD for epilepsy, and highlights issues related to the use of currently available CBD products.
This study combats the notion that CBD causes a THC high by discussing the misinterpretations of prior studies on the subject. In fact, the researchers state that two particular prior studies “have caused much confusion and uncertainty whether oral cannabidiol (CBD) is safe and whether subjects who are treated with CBD run the risk of positive workplace tests [for THC].”
Love Hemp Ltd. is also an ethical promoter of high-quality CBD products who does not engage in dubious advertising techniques. Their product information and labelling are transparent and all products possess third-party certification. They recently partnered with UFC fighters when they saw how CBD had changed their lives. These may not be the ultimate reference models for a health-conscious market, but they’re certainly an interesting testimonial to listen to, as they’re very conscious of their performance and value the importance of recovery after strenuous mental stress and physical exercise. Love Hemp is responsible for breaking ground and shifting the UK public’s perception of cannabis as a source of vegan goodness for people of all ages and creeds. Visit the Love Hemp collection.
There are likely very complex relationships also occurring between various Cannabinoids in Cannabis that may lead to certain medical efficacy. That is important to remember when considering the consumption of products that contain Cannabinoids. There is an attractiveness to isolating a specific chemical, researching it, patenting synthetic derivatives, and marketing specific drugs. That said, the relationships are complex, will likely take years to understand, and many patients I’ve met appear to find the most medical benefit from a diverse group of Cannabinoids whose interactions are not particularly well understand, but the results are hard to argue with.

Although CBD oils aren’t regulated by the FDA, purchasing products stateside from one of the nine states where recreational and medical cannabis use is legal will likely result in a higher-quality product than buying one made with hemp-derived CBD oil imported from abroad, says Martin Lee, director of Project CBD, a nonprofit that promotes medical research into CBD.
×